TAUDIA

AgentT

This diagnostics company develops blood tests for early Alzheimer's disease detection to support pharmaceutical drug development and clinical screening.

BrainDTech

The company develops a diagnostic platform using microRNA biomarkers from liquid biopsies for the early detection and monitoring of neurodegenerative diseases for healthcare providers.

Pre Diagnostics

This company develops intracellular blood tests and biomarker analytical services for the early detection of Alzheimer's disease for patients, practitioners and researchers.

Promental Health

Promental Health develops a blood test using microRNA biomarkers and machine learning for the early diagnosis of Alzheimer's disease for healthcare providers.

ADmit Therapeutics

ADmit Therapeutics develops blood-based epigenetic tests for early Alzheimer's disease detection to assist pharmaceutical companies and healthcare providers with clinical trials and patient care.

Neurovision

This company provides diagnostic blood tests and retinal imaging software to help healthcare providers detect and monitor neurodegenerative diseases.

ViewMind

ViewMind develops eye-tracking cognitive assessment tools for pharmaceutical researchers and healthcare providers to detect and monitor neurodegenerative diseases and brain health.

Alzeca Biosciences

This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.